Concord Healthcare Completes HK$68 Million Convertible Bond Issue to CSPC Pharma Unit

MT Newswires Live
05/14

Concord Healthcare (HKG:2453) completed the issuance of HK$68 million convertible bonds to a unit of CSPC Pharmaceutical (HKG:1093), according to a Wednesday Hong Kong bourse filing.

Shares of the medical services firm were down over 2% in Thursday morning trade.

The company issued the 2% convertible bonds due April 2027 to Dragon Merit after all conditions under the placing and subscription agreement were fulfilled.

The bonds are convertible into as much as 40 million Hong Kong-listed shares at an initial conversion price of HK$1.70 per share.

Concord Healthcare previously said net proceeds of about HK$63.1 million would mainly be used to repay loans and supplement working capital.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10